For eligible patients with End-Stage Renal Disease (ESRD), kidney transplantation offers superior quality of life and improved survival compared with long-term maintenance dialysis.

The Evaluation & Matching Process

Recipient and prospective donor undergo thorough immunologic compatibility testing, including ABO blood grouping, HLA human leukocyte antigen typing, and crossmatch tests to evaluate panel-reactive antibodies.

Life After Transplantation

Successful engraftment requires strict adherence to lifelong immunosuppressive medications to prevent organ rejection, coupled with routine surveillance of renal function biomarkers and infection prophylaxis.